Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review

Multiple myeloma (MM) is a clonal malignancy characterized by the proliferation of malignant plasma cells in the bone marrow and the production of monoclonal immunoglobulin. Although some newly approved drugs (thalidomide, lenalidomide, and bortezomib) demonstrate significant benefit for MM patients...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xuepeng, Yang, Kai, Chen, Peng, Liu, Bing, Zhang, Yuan, Wang, Fang, Guo, Zhi, Liu, Xiaodong, Lou, Jinxing, Chen, Huiren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166211/
https://www.ncbi.nlm.nih.gov/pubmed/25246802
http://dx.doi.org/10.2147/OTT.S67165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166211/
https://www.ncbi.nlm.nih.gov/pubmed/25246802
http://dx.doi.org/10.2147/OTT.S67165

Ejemplares similares